Tissue healing support

"Tissue healing support" encompasses the broad set of cellular and molecular processes that lead to the repair of injured tissues. This involves a tightly orchestrated sequence of events typically divided into hemostasis, inflammation, proliferation, and remodeling phases. Key players include platelets (for clotting and release of growth factors), immune cells like neutrophils and macrophages (for pathogen clearance and regulation of inflammation), fibroblasts (for extracellular matrix synthesis), endothelial cells (for new blood vessel formation), and keratinocytes (for re-epithelialization)[1][2][3][5][6][7]. There is no single molecule, receptor, or defined therapeutic target named "Tissue healing support." Instead, effective tissue repair depends on the coordination of many different cell types and signaling molecules. Therapies aimed at "tissue healing support" typically target specific steps or mediators within this process, rather than a unique molecular target. Summary: "Tissue healing support" does not correspond to a unique or canonical protein, gene, receptor, or other standard therapeutic target. It should not be treated as a molecular target for purposes like drug development or biomarker selection. Instead, identifying relevant targets requires specifying particular molecular components or pathways within the tissue repair process (e.g., "Macrophage," "Platelet-derived growth factor receptor," "Vascular endothelial growth factor receptor," etc.)[1][2][3][5][6][7].

Other names

Wound healing supportTissue repair promotionRegenerative support